Health
Pfizer and BioNTech coronavirus vaccine accepted for rolling review in Canada – Motley Fool Australia
Health Canada will determine BNT162b2’s suitability for approval as clinical trial data comes in.
This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
The coronavirus vaccine candidate being developed by Pfizer(NYSE: PFE) and BioNTech(NASDAQ: BNTX) is now undergoing its first regulatory review in North America. The two companies announced that their BNT162b2 has been accepted for a rolling review by Health Canada, that country’s healthcare regulatory authority.
A rolling review is one undertaken while a candidate is still in developme…
-
Noosa News24 hours agoSerious traffic crash, Noosa – Sunshine Coast
-
Noosa News24 hours ago$20 million program to help women return to work
-
General20 hours agoThousands join pro-Palestinian rallies in towns and cities across Australia amid ceasefire
-
General19 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test